Future of Psychedelic Therapy
The conversation delves into the anticipated timeline for FDA approval of psychedelic therapies, emphasizing the ongoing phase three trials aimed at treating conditions like depression and PTSD. With a focus on natural substances and their potential clinical applications, the discussion highlights the importance of a controlled environment for administering these therapies, contrasting them with recreational use. Philanthropic funding plays a crucial role in advancing this research, paving the way for a new era in mental health treatment.In this clip
From this podcast
The Doctor's Farmacy with Mark Hyman, M.D.
Are Psychedelics the New Wonder Drug for Mental Illness and the Fear of Death?
Related Questions